AU2004224448A1 - Detection and monitoring of lung cancer - Google Patents

Detection and monitoring of lung cancer Download PDF

Info

Publication number
AU2004224448A1
AU2004224448A1 AU2004224448A AU2004224448A AU2004224448A1 AU 2004224448 A1 AU2004224448 A1 AU 2004224448A1 AU 2004224448 A AU2004224448 A AU 2004224448A AU 2004224448 A AU2004224448 A AU 2004224448A AU 2004224448 A1 AU2004224448 A1 AU 2004224448A1
Authority
AU
Australia
Prior art keywords
polynucleotides
sequence
patient
seq
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004224448A
Other languages
English (en)
Inventor
Dawn C. J. Hayes
Raymond L. Houghton
Barbara K. Zehentner-Wilkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2004224448A1 publication Critical patent/AU2004224448A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2004224448A 2003-03-24 2004-03-10 Detection and monitoring of lung cancer Abandoned AU2004224448A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45726103P 2003-03-24 2003-03-24
US60/457,261 2003-03-24
US50299503P 2003-09-15 2003-09-15
US60/502,995 2003-09-15
PCT/US2004/007451 WO2004084804A2 (en) 2003-03-24 2004-03-10 Detection and monitoring of lung cancer

Publications (1)

Publication Number Publication Date
AU2004224448A1 true AU2004224448A1 (en) 2004-10-07

Family

ID=33101281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004224448A Abandoned AU2004224448A1 (en) 2003-03-24 2004-03-10 Detection and monitoring of lung cancer

Country Status (6)

Country Link
US (1) US20070042368A1 (enExample)
EP (1) EP1606303A4 (enExample)
JP (1) JP2006521110A (enExample)
AU (1) AU2004224448A1 (enExample)
CA (1) CA2520512A1 (enExample)
WO (1) WO2004084804A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171091A1 (en) * 2003-02-27 2004-09-02 Cell Work, Inc. Standardized evaluation of therapeutic efficacy based on cellular biomarkers
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) * 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
ES2620294T3 (es) 2008-09-20 2017-06-28 The Board Of Trustees Of The Leland Stanford Junior University Diagnóstico no invasivo de la aneuploidia fetal por secuenciación
TW202409288A (zh) * 2022-07-25 2024-03-01 美商英特瑞斯生物療法公司 突變多肽、包含該等突變多肽之組合物及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US660833A (en) * 1900-05-22 1900-10-30 Harry W Bell Partition.
US5795723A (en) * 1994-05-06 1998-08-18 Fred Hutchinson Cancer Research Center Expression of neurogenic bHLH genes in primitive neuroectodermal tumors
US6706262B1 (en) * 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6821518B1 (en) * 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) * 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) * 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6210883B1 (en) * 1998-03-18 2001-04-03 Corixa Corporation Compounds and methods for diagnosis of lung cancer
US6518256B1 (en) * 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
US20030125245A1 (en) * 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6686447B1 (en) * 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002002623A2 (en) * 2000-06-29 2002-01-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
CA2415544A1 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
CA2444691A1 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US20030103994A1 (en) * 2001-06-28 2003-06-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
JP2006521110A (ja) 2006-09-21
EP1606303A2 (en) 2005-12-21
WO2004084804A3 (en) 2005-06-16
CA2520512A1 (en) 2004-10-07
US20070042368A1 (en) 2007-02-22
WO2004084804A2 (en) 2004-10-07
EP1606303A4 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
EP1272668B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
KR20190026769A (ko) 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
WO2011160585A1 (en) Micro-rna markers for colorectal cancer
JP2008510454A (ja) 肺癌および乳癌におけるマーカーの同定
US20030170631A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
EP3692165A1 (en) Method for body fluid identification
US20070042368A1 (en) Detection and monitoring of lung cancer
JP2004500895A (ja) 肺癌用遺伝子マーカー
KR102555330B1 (ko) SARS-CoV-2 진단용 조성물, 키트 및 이를 이용한 SARS-CoV-2의 진단방법
CN108866187B (zh) 一种与肺癌辅助诊断相关的长链非编码rna标志物及其应用
US20140072971A1 (en) Prame detection assays
WO2001083816A2 (en) Method for detecting tumors
JPWO2018123764A1 (ja) 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法
EP1892304B1 (en) Method and kit for detection of microsatellite instability-positive cell
CN118308502A (zh) 检测结核分枝杆菌耐药基因的引物组、试剂盒及方法
JPH08510649A (ja) Ｂｃ２００ｒｎａ、それに対するプローブ及びその使用
CN114410795A (zh) 基于miRNA特征标记的肝癌早期检测
JP4315812B2 (ja) 癌腫の分子診断および予後
US20060292600A1 (en) Methods, compositions and kits for the detection and monitoring of lung cancer
JP4889258B2 (ja) ウシ白血病発症に対する抵抗性の判定方法
KR102478811B1 (ko) 멀티플렉스 ｐｃｒ 플랫폼 기반의 알츠하이머 질환 진단을 위한 신규한 마커 조성물 및 이의 용도
EP1660676B1 (en) Diagnosis of risk of breast cancer
JP2001269174A (ja) 骨髄異形成症候群（ｍｄｓ）の検出方法及びｍｄｓの治療剤
CN109750043B (zh) 含lncRNA的系统性红斑狼疮检测试剂及其用途
HK40081979A (en) Composition for diagnosing sars-cov-2, kit, and method for diagnosing sars-cov-2 by using same

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application